A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol.
Milagros Gonzalez-RiveraAntoni C PicornellEnrique L ÁlvarezMiguel MartinPublished in: JMIR research protocols (2016)
ClinicalTrials.gov NCT02626039; https://clinicaltrials.gov/ct2/show/NCT02626039 (Archived by WebCite at http://www.webcitation.org/6jlneVyoz).
Keyphrases
- cell free
- metastatic breast cancer
- circulating tumor cells
- circulating tumor
- study protocol
- randomized controlled trial
- squamous cell carcinoma
- image quality
- small cell lung cancer
- computed tomography
- dual energy
- contrast enhanced
- clinical trial
- positron emission tomography
- open label
- magnetic resonance imaging
- double blind
- clinical evaluation
- single molecule